S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022
Sponsored by: Sen. Patty Murray
Committee On Health, Education, Labor, And Pensions. Reported By Senator Murray With An Amendment In The Nature Of A Substitute. Without Written Report. on 07/13/2022
You have voted S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022.
HB-7585: Health Equity and Accountability Act of 2022 Correcting Hurtful and Alienating Names in Government Expression (CHANGE) Act Kidney Disease Research, Surveillance, Prevention and Treatment Improvement Act of 2022 Stop HIV in Prison Act Bone Marrow Failure Disease Research and Treatment Act of 2020 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2022 Immigrants’ Mental Health Act of 2022 Menstrual Equity For All Act of 2021 Data to Save Moms Act Sleep and Circadian Rhythm Disorders Health Disparities Act End Tuberculosis Act Universal School Meals Program Act of 2022
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 06/29/2022
You have voted HB-7585: Health Equity and Accountability Act of 2022 Correcting Hurtful and Alienating Names in Government Expression (CHANGE) Act Kidney Disease Research, Surveillance, Prevention and Treatment Improvement Act of 2022 Stop HIV in Prison Act Bone Marrow Failure Disease Research and Treatment Act of 2020 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2022 Immigrants’ Mental Health Act of 2022 Menstrual Equity For All Act of 2021 Data to Save Moms Act Sleep and Circadian Rhythm Disorders Health Disparities Act End Tuberculosis Act Universal School Meals Program Act of 2022.
American Made Pharmaceuticals Act of 2022 [HB-7400]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Manufacturing ]
[Trade ]
[Budget and Spending ]
[Public Health ]
To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
HB-7400: American Made Pharmaceuticals Act of 2022
Sponsored by: Sen. Markwayne Mullin
Referred To The Subcommittee On Health. on 04/06/2022
American Made Pharmaceuticals Act of 2022 [S.3991]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Manufacturing ]
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
S.3991: American Made Pharmaceuticals Act of 2022
Sponsored by: Sen. Tom Cotton
Read Twice And Referred To The Committee On Finance. on 04/05/2022
Ending Discrimination in COVID–19 Treatments Act [S.3974]
[Healthcare ]
[Public Health ]
[Race and Civil Rights ]
[Veterans ]
[Disabilities ]
A bill to prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government.
S.3974: Ending Discrimination in COVID–19 Treatments Act
Sponsored by: Sen. Ted Cruz
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/31/2022
Equitable Community Access to Pharmacist Services Act [HB-7213]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Public Health ]
[Senior Citizens ]
[Social Security ]
[Funding ]
[Grants ]
To amend title XVIII of the Social Security Act to provide pharmacy reimbursement for COVID-19-related and future emergency services.
HB-7213: Equitable Community Access to Pharmacist Services Act
Sponsored by: Rep. David Valadao
Referred To The Subcommittee On Health. on 03/25/2022
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 [HB-6833]
[Healthcare ]
[Pharmaceuticals ]
[Budget and Spending ]
To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.
HB-6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Sponsored by: Rep. Gerald Connolly
Became Public Law No: 117-180. on 09/30/2022
HB-6832: To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
Sponsored by: Rep. Andy Biggs
Referred To The Subcommittee On Health. on 02/28/2022
You have voted HB-6832: To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic..
Affordable Insulin Now Act [S.3700]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Insurance ]
A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans.
S.3700: Affordable Insulin Now Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Finance. on 02/17/2022
Opioid Treatment Access Act of 2022 [S.3629]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
A bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency, and for other purposes.
S.3629: Opioid Treatment Access Act of 2022
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/10/2022
Equal Access to Therapeutics Act [HB-6625]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
To prohibit the Secretary of Health and Human Services from issuing guidance intended to restrict access to COVID-19 monoclonal antibody therapies and other treatments.
HB-6625: Equal Access to Therapeutics Act
Sponsored by: Rep. Glenn Grothman
Referred To The Subcommittee On Health. on 02/08/2022
S.3489: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
Sponsored by: Sen. Richard Burr
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/12/2022
You have voted S.3489: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes..
S.3440: A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
Sponsored by: Sen. Ted Cruz
Read Twice And Referred To The Committee On Banking, Housing, And Urban Affairs. on 01/04/2022
You have voted S.3440: A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic..
Sponsored by: Sen. Edward Markey
Committee On Foreign Relations. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 12/07/2022
Opioid Treatment Access Act of 2022 [HB-6279]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
To authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency, and for other purposes.
HB-6279: Opioid Treatment Access Act of 2022
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 11/01/2022